Please note that this website uses cookies necessary for the functioning of our website, cookies that optimize the performance, to provide social media features and to analyse website traffic.

Dear Ms Garde,  5-03-2023

It is now over four months since you acknowledged receipt of an e-mail from me raising concerns re Professor Anthony Pollard's fitness to practice medicine in the UK. I quote you:


 On 24/10/2022 11:46 am, This email address is being protected from spambots. You need JavaScript enabled to view it. wrote:Your GMC reference number: 0324409

Dear Dr Halpin

Thank you for contacting us about Sir Anthony John Pollard

I have forwarded your letter to the fitness to practise department for the attention of Anthony Omo.

If you would like to discuss this further, please call us using the number below or reply to this email.

Yours sincerely

Mandy

Mandy Garde
Contact Centre Adviser,
Registration and Revalidation Directorate

Telephone: 0161 923 6602 (+44 161 923 6602 from outside the UK)
Website: www.gmc-uk.org

I have had no word from the GMC since. My great concerns regarding this doctor deepen - in part because the harms that have been and are being done are multiple and growing greatly in number.  But also because of this -

https://www.globalresearch.ca/vaccine-target-week-reduced-30000-doses-due-precautionary-pause-astrazeneca-use/5739808    dated 15-03-2021

Please bring this latter report to Mr Omo immediately.

This report 14-03-2022 substantiates that above

https://www.thejournal.ie/astrazeneca-suspension-ireland-5380974-Mar2021/  14-03-2021

I quote from this HMG announcement

https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement-7-may-2021/use-of-the-astrazeneca-covid-19-azd1222-vaccine-updated-jcvi-statement-7-may-2021  

Should there be a deterioration in any of the above factors, JCVIadvises that vaccination of adults aged 30 to 39 years with any of the UK-authorised vaccines is always better than no vaccination, except where there are specific contraindications.

Due to its storage and transport requirements, the AstraZeneca (AZD1222) vaccine is much more easily delivered in some settings, and in these settings may be the only vaccine it is practical to offer. In such circumstances JCVIadvises that the benefits of receiving the AstraZeneca (AZD1222) vaccine outweigh the risks, and individuals in this event should be offered the AstraZeneca (AZD1222) vaccine.

So two months after some European nations had withdrawn the AS 'vaccine' and use had been 'paused' in Eire, it was still being inoculated in the UK, and almost always without informed consent.  The latter is both an ethical and criminal matter.

Professor Pollard as the 'inventor' would have been fully aware of the 'adverse reactions' being reported on the 'yellow card' gov.uk website and in newspaper reports in these 2 months. eg A 25 yr old fit male from this parish of Ilsington, Devon perished in the QE Birmingham hospital with multiple cerebral haemorrhages and thromboses after receiving the Astra Zeneca experimental material (no 2 yr long controlled trial). Cerebral venous thrombosis was recorded in some as occurring very unusually in the sagittal sinus.

He has been negligent and this is a further reason for his licence  to practice being questioned.

Please update me within the next 7 days as to the progress of Mr Omo's investigation of my most serious complaints, which centrally included the questions I asked of him, but without an acknowledgement nor substantive reply. Repeated now for convenience -

The questions I posed Professor Pollard are these -

1.  Please identify the adenovirus of the 'chimpanzee'.
2.  Was this one chimpanzee or several?
3.  How was disease caused by this adenovirus expressed in this or several primates?
4.  What veterinary diagnosis was made in these animals?
5.  Bearing this quotation from   https://en.wikipedia.org/wiki/Adenoviridae   in mind  - 

A replication-deficient chimpanzee adenovirus vaccine vector (ChAdOx1) is used by the Oxford–AstraZeneca COVID-19 vaccine that has been approved for use.[47][48]

How stable is this adenovirus once a strand of amino-acids that trigger production of 'spike protein' in the human victims, is spliced into this pathogen of a primate/s?

6. And I note this second sentence  in this Wikip[edia account of Adenoviridae -
They have a broad range of vertebrate hosts; in humans, more than 50 distinct adenoviral serotypes have been found to cause a wide range of illnesses, from mild respiratory infections in young children (known as the common cold) to life-threatening multi-organ disease in people with a weakened immune system.[2]

yours faithfully

David Halpin MB BS FRCS


 

This letter has been sent by e-mail to the GMC - This email address is being protected from spambots. You need JavaScript enabled to view it.

I have asked questions of Professor Sir Andrew John Pollard BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FIDSA, FRCPCH, MA, FmedSc relevant to his conception, production and promotion of the Oxford Vaccine Group/Astra Zeneca material used for some months in the Covid_19 epidemic. Professor Pollard is expert in the field of immunology and has been honoured widely. https://www.ovg.ox.ac.uk/team/sir-andrew-pollard

GMC registration number 3309568. MB BS London 1989.

Provisional registration date 15 Jul 1989. Full registration date 01 Aug 1990.

The correspondence starting 25-07-2022, with further e-mails 3-08 and 12-08-2022 urging a reply, is recorded on my own website https://dhalpin.infoaction.org.uk/ and is here attached (1). It arose from the finding of advanced rectal cancer in our daughter Fiona, with a history of symptoms going back approximately 12 weeks. She required a colostomy for near complete intestinal obstruction. She is receiving chemotherapy; a CAT scan is planned in 4 weeks to see if there has been good effect. She feels generally well and is in good spirits.

I am questioning whether there is any connection between the inoculation of the Oxford/Astra Zeneca product in March and May of 2021 and our daughter’s malignancy. I ask this because Ryan Cole MD, a pathologist in the USA, is reporting marked increases in cancer since the ‘roll out’ of ‘vaccines’, especially of uterine cancers and malignant melanomas. (2) Ute Kruger MD, a pathologist trained in Germany and serving in Sweden, has also put forward the hypothesis that cancers are being initiated by these’vaccines’ and dormant cancers made active. (3)

The questions I posed Professor Pollard are these -

1.  Please identify the adenovirus of the 'chimpanzee'.
2.  Was this one chimpanzee or several?
3.  How was disease caused by this adenovirus expressed in this or several primates?
4.  What veterinary diagnosis was made in these animals?
5.  Bearing this quotation from   https://en.wikipedia.org/wiki/Adenoviridae   in mind  - 

A replication-deficient chimpanzee adenovirus vaccine vector (ChAdOx1) is used by the Oxford–AstraZeneca COVID-19 vaccine that has been approved for use.[47][48]

How stable is this adenovirus once a strand of amino-acids that trigger production of 'spike protein' in the human victims, is spliced into this pathogen of a primate/s?

6. And I note this second sentence  in this Wikip[edia account of Adenoviridae -
They have a broad range of vertebrate hosts; in humans, more than 50 distinct adenoviral serotypes have been found to cause a wide range of illnesses, from mild respiratory infections in young children (known as the common cold) to life-threatening multi-organ disease in people with a weakened immune system.[2]


I ask these questions of a fellow doctor out of concern for our daughter, but also out of concern for others here in the UK and world wide. It is very evident that cancers are arising at unusual ages and of unusual cell type for age following ‘vaccination’. That alone should be sufficient for the doctor who was the font for this inoculation to give me answers.

Three other duties come to mind.

ONE  His duty to ‘do no harm’. The latter a paraphrasing of Hippocrates’ oath.  And central to the formation of the General Medical Council in 1858 by the UK Parliament.  To "protect, promote and maintain the health and safety of the public"

TWO His statutory duty to respond under the Freedom of Information Statutes

THREE  His statutory duty of candour.

For instance - he planned and promoted with others a trial of this product on children in 7 cohorts from the age of 6 to 17 yrs. This was to be carried out in 5 DGHs. Unlike the general ‘roll out’, the parents would have had more detail in the process leading to 'consent'. In the general context there has been no informed consent, and is thus both illegal and unethical.

I opposed this trial of this product on children, partly because it was experimental, but especially because there was no necessity given the excellent natural immunity in the child and a known miniscule mortality. (4)  I informed the Chief Constable of Thames Valley about this trial, in the belief that this was a criminal assault. (5) The trial went ahead but was stopped prematurely. I e-mailed his department at Oxford asking why it was stopped but had no response. It is easy to think that there were adverse reactions.

I ask that Dr Anthony Pollard’s place on the register be considered by Mr Anthony Omo, Director of Fitness to Practise. I add that a medical qualification would in logic be necessary for this function, especially given the complexity of medical practice now, the multiple pressures on doctors, the lack of autonomy etc.

David Halpin MB BS FRCS

1. https://dhalpin.infoaction.org.uk/52-articles/covid-19/385-our-54-yr-old-daughter-with-advanced-low-rectal-cancer-relevance-of-astrazeneca-oxford-vaccination

2. https://gospelnewsnetwork.org/2022/07/18/pathologist-dr-ryan-cole-speaks-out-about-covid-jab-effects/  Please read text rather than view the video.

3. https://www.globalresearch.ca/turbo-cancer-we-have-problem/5789172

4. https://dhalpin.infoaction.org.uk/52-articles/covid-19/356-c19-vaccine-to-16-and-17-yr-olds

5. https://dhalpin.infoaction.org.uk/52-articles/covid-19/343-assault-on-children-in-a-trial-of-a-vaccine-by-the-oxford-group-and-astra-zeneca-for-which-there-is-no-need